The US multicenter double-blind, randomized, phase III trial of thymoglobulin versus Atgam in the treatment of acute graft rejection episodes following renal transplantation: Rationale for study design

T. J. Schroeder, L. W. Moore, L. W. Gaber, A. O. Gaber, M. R. First

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'The US multicenter double-blind, randomized, phase III trial of thymoglobulin versus Atgam in the treatment of acute graft rejection episodes following renal transplantation: Rationale for study design'. Together they form a unique fingerprint.